Get alerted on the PharmaSources E-Newsletter and Pharma Sources Insight E-Compilation!
Note: You can unsubscribe from the alerts at any time.
Advertising

Daiichi Sankyo initiates study of U3-1402 in patients with breast cancer

pharmaasiaFebruary 16, 2017

Tag: Daiichi Sankyo , f U3-1402

PharmaSources Customer Service